Immunovant Sciences Gmbh
Clinical trials sponsored by Immunovant Sciences Gmbh, explained in plain language.
-
New drug tested for Hard-to-Treat thyroid condition
Disease control CompletedThis study tested whether a drug called batoclimab could help control Graves' disease in adults whose thyroid hormone levels remained too high despite standard medication. Thirty-five participants received batoclimab injections for 24 weeks while researchers monitored their thyro…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New injection shows promise for reducing bulging eyes in thyroid condition
Disease control CompletedThis completed Phase 3 trial tested whether weekly injections of an experimental drug called batoclimab could reduce eye bulging (proptosis) and inflammation in people with active Thyroid Eye Disease. The study involved 114 adults who received either the drug or a placebo for 24 …
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC